Plyometric-Based Hydro-Kinesio Therapy in Children With Hemophilic Arthropathy (NCT05947110) | Clinical Trial Compass
CompletedNot Applicable
Plyometric-Based Hydro-Kinesio Therapy in Children With Hemophilic Arthropathy
Saudi Arabia48 participantsStarted 2021-09-05
Plain-language summary
This study was designed to assess the effect of an 8-week plyometric-based hydro-kinesio therapy (Plyo-HKT) on pain, muscle strength, postural control, and functional performance in a convenience sample of children with hemophilic knee arthropathy (HKA). Forty-eight patients with HKA were randomly allocated to the Plyo-HKT group (n = 24, received the plyometric-based hydro-kinesio therapy program, twice/week, over 8 weeks) or the control group (n = 24, received standard exercise program). Both groups were assessed for pain, muscle strength, postural control, and functional performance pre and post-treatment.
Who can participate
Age range
8 Years – 16 Years
Sex
MALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Eight and 16 years.
* Had factor VIII replacement prophylaxis.
* Clinically-stable.
* Unilateral knee involvement.
* Knee arthropathy of grade II or III per the Arnold-Hilgartner radiographic classification.
* Muscle strength of grade 3 in lower limb muscles.
* Use of no pain medication for one month prior to enrollment.
* Walking independently.
Exclusion Criteria:
* Enduring disabling pain
* Fixed deformities.
* History of musculoskeletal surgery.
* Visual or vestibular deficits.
* Engagement in regular exercises.
* Bleeding episodes within two weeks prior to enrolment.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.